Marika Guercio
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
CD19 antigen: from tumor target to safety switch in CAR-T cell therapy.
Journal: Haematologica
Published: April 07, 2026
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.
Journal: Nature medicine
Published: September 09, 2025
Furuncular myiasis by Cordylobia anthropophaga in three Italian children: First case series and implications for non-endemic regions.
Journal: PLoS neglected tropical diseases
Published: September 05, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.
Journal: Nature medicine
Published: March 01, 2025
Truncated form of human CD19 antigen as a suicide gene to control T-cell alloreactivity: ΔCD19.
Journal: Haematologica
Published: January 13, 2025
Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells.
Journal: Journal of hematology & oncology
Published: July 11, 2024
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma.
Journal: Nature medicine
Published: February 09, 2024
Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational study.
Journal: Heliyon
Published: July 31, 2023
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 21, 2023
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma.
Journal: The New England journal of medicine
Published: April 05, 2023
Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy.
Journal: Frontiers in immunology
Published: March 31, 2023
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters.
Journal: Frontiers in immunology
Published: March 26, 2023
Last Updated: 09/26/2026